West Pharmaceutical Services, Inc. (WST)

Pros

1. WST average analyst rating is Buy. See WST analyst rating chart.
2. WST average analyst price target ($386.50) is above its current price ($341.89). See WST price target chart.

Cons

1. WST quarterly revenue growth was 7.40%, lower than the industry and sector average revenue growth (10.76% and 7.51%, respectively). See WST revenue growth chart.
2. WST profitability is declining. The YoY profit margin change was -0.09 percentage points. See WST profitability chart.
3. WST forward P/E ratio is 37.96, which is high compared to its industry peers’ P/E ratios. See WST forward P/E ratio chart.
4. WST PEG ratio (P/E adjusted for growth) is 3.06, which is high compared to its industry peers’ PEG ratios. See WST PEG chart.